Prognostic Factors of Gliosarcoma in the Real World: A Retrospective Cohort Study

Figure 1

(a, b) Horizontal T1-weighted contrast-enhanced MRI imaging of GSM located in the temporal lobe. (c–f) Representative images of GSM stained using HE and immunolabeled using antibodies to GFAP, IDH1, and Ki-67. Through HE staining (c) and GFAP (d) staining, it can be observed in the biphasic growth pattern of GFAP-positive glioma components and GFAP-negative sarcoma components.

(a)

(b)

(c)

(d)

(e)

(f)